Miralax Clinical Trials and Studies

Miralax Information

Miralax Clinical Trials and Studies

In one study, patients with less than 3 bowel movements per week were randomized to Miralax, 17 grams, or placebo for 14 days. An increase in bowel movement frequency was observed for both treatment groups during the first week of treatment. Miralax was statistically superior to placebo during the second week of treatment.

In another study, patients with 3 bowel movements or less per week and/or less than 300 grams of stool per week were randomized to 2 dose levels of Miralax or placebo for 10 days each. Success was defined by an increase in both bowel movement frequency and daily stool weight. For both parameters, superiority of the 17 gram dose of Miralax over placebo was demonstrated.

Miralax Information